eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Check drugs       Compare drugs       Join a support group

Would you have Baldness (Hair loss) when you have Asthma?

Summary: Baldness is found among people with Asthma, especially people who are female, 40-49 old, also have High blood pressure, and take medication Singulair.

We study 378 people who have Baldness (Hair loss) and Asthma from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Asthma and Baldness >>>



Asthma can be treated by Singulair, Symbicort, Advair Diskus 250/50, Albuterol Sulfate, Albuterol, Ventolin. (latest reports from 84,471 Asthma patients)


Baldness (partial or complete lack of hair growth) has been reported by people with high blood pressure, rheumatoid arthritis, high blood cholesterol, multiple sclerosis, depression. (latest reports from 42,734 Baldness patients)

On Feb, 27, 2015: 378 people who have asthma and Baldness are studied.

Trend of Baldness in asthma reports

Gender of people who have asthma and experienced Baldness * :


Age of people who have asthma and experienced Baldness * :


Severity of the symptom * :

leastmoderateseveremost severe

Top co-existing conditions for these people * :

  1. Hypertension (46 people, 12.17%)
  2. Hypothyroidism (33 people, 8.73%)
  3. Depression (31 people, 8.20%)
  4. Diabetes mellitus (28 people, 7.41%)
  5. Osteoporosis (27 people, 7.14%)
  6. Rheumatoid arthritis (25 people, 6.61%)
  7. Prophylaxis (20 people, 5.29%)
  8. Gastric disorder (20 people, 5.29%)
  9. Blood cholesterol increased (20 people, 5.29%)
  10. Hypersensitivity (17 people, 4.50%)

Most common drugs used by these people * :

  1. Singulair (121 people, 32.01%)
  2. Xolair (87 people, 23.02%)
  3. Albuterol (62 people, 16.40%)
  4. Symbicort (60 people, 15.87%)
  5. Humira (50 people, 13.23%)
  6. Spiriva (44 people, 11.64%)
  7. Fosamax (28 people, 7.41%)
  8. Methotrexate (27 people, 7.14%)
  9. Ventolin (26 people, 6.88%)
  10. Synthroid (25 people, 6.61%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of asthma and baldness on

Do you have Asthma and Baldness?




You are not alone! Join a support group on :
- support group for people who have Baldness and Asthma
- support group for people who have Asthma
- support group for people who have Baldness

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Asthma related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.